Physician profile
William Stuart Bikoff
NPI 1285678185
$960.83
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $366 · 2021: $228 · 2022: $79.28 · 2024: $16.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $213.46 | 2019-2020 | |
| Ucb, INC. | $117.53 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $75.64 | 2019-2020 | |
| Abbvie INC. | $67.16 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $51.90 | 2020-2021 | |
| Amgen INC. | $50.17 | 2020 | |
| Janssen Pharmaceuticals, INC | $44.75 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $37.22 | 2020-2021 | |
| Sk Life Science, INC. | $34.82 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $34.66 | 2021 | |
| Biogen, INC. | $30.05 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.64 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $23.35 | 2020 | |
| Horizon Therapeutics Plc | $22.77 | 2021 | |
| Mdd US Operations, LLC | $21.13 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.40 | 2022 | |
| Acadia Pharmaceuticals INC | $16.65 | 2019 | |
| Harmony Biosciences LLC | $16.51 | 2024 | |
| Impel Pharmaceuticals INC. | $13.95 | 2022 | |
| Upsher-Smith Laboratories LLC | $13.29 | 2020 | |
| Boston Scientific Corporation | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bikoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.